Patents Represented by Attorney Ted Whitlock
  • Patent number: 8329673
    Abstract: Described herein are alkylated and semi-synthetic glycosaminoglycosan ethers, referred to herein as “SAGEs.” The synthesis of sulfated and alkylated SAGEs is also described. The compounds described herein are useful in a number of applications including use for ocular or ophthalmic treatment.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: December 11, 2012
    Assignee: University of Utah Research Foundation
    Inventors: Glenn D. Prestwich, Jianxing Zhang, Thomas P. Kennedy, Narayanam V. Rao
  • Patent number: 7713547
    Abstract: A drug-containing pharmaceutical tablet adapted for accurate breaking which has two or more segments with at least one segment containing a drug.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: May 11, 2010
    Assignee: Accu-Break Pharmaceuticals, Inc.
    Inventors: Lawrence Solomon, Allan S. Kaplan
  • Patent number: 7625940
    Abstract: A method for the treatment of systemic arterial hypertension, which is based on the oral administration to a patient suffering from systemic arterial hypertension either in an amount of chlorthalidone of 2.5-10 mg daily, alone or in novel combination use with another anti-hypertensive.agent.
    Type: Grant
    Filed: July 1, 2005
    Date of Patent: December 1, 2009
    Assignee: Accu-Break Technologies, Inc.
    Inventor: Lawrence Solomon